Black, Hispanic, & Asian patients in our hospitals are receiving less supplemental oxygen than White patients because of racial bias in pulse oximetry.

jamanetwork.com/journals/jamai… Huge thanks to @egottliebMD for sharing his work w/ the @BrighamWomens Ethics Committee today (after a night shift!). @MITCriticalData

1/ In 2008, @US_FDA phased out #albuterol inhalers w/ ozone-depleting CFCs, including several generics.

Since then, brand-name firms have reaped $14 billion in sales on albuterol products--though the active ingredient went off #patent in 1989!

nejm.org/doi/full/10.10…

🧵👇 2/ The first #albuterol inhalers came to the market in 1981.

By the mid-1990s, inexpensive generics had become available.

1/ New paper out w/ @bnrome @Beatrice__Brown @akesselheim @PORTAL_Research examines how top-performing hospitals mark up prices on clinician-administered drugs.

🧵 below.

jamanetwork.com/journals/jamai… 2/ As of January 1, 2021, hospitals must now post payer-specific prices for all goods and services, including clinician administered drugs.

nejm.org/doi/full/10.10…

📄📄New article in @JAMAHealthForum 📄📄

We take a deep dive into the question of how to estimate rebates and other discounts received by Medicare #PartD.

With @bnrome, #VeroniqueRaimond, #JoshGagne, @akesselheim @PORTAL_Research

Thread below.

ja.ma/3z5mAx6 1/ First some background.

There are 2 broad categories of discounts in Medicare #PartD: direct and indirect remuneration (#DIR) and coverage gap discounts (#CGD).